Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Timothée Olivier · SciRah

Researcher profile · Semantic Scholar

Timothée Olivier

Share profile

Timothée Olivier — researcher profile on SciRah

h-index: 2
Works: 8
Citations: 54

Most-cited papers

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Maxime Borgeaud, Timothée Olivier, J. Bar, S. Saw +6 more
2025Ca49 citations Open access
Semantic Scholar
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors
Hiba Mechahougui, L. Royston, Catia Vieira Gomes, L. Kaiser +6 more
2026Clinical Cancer Research3 citations Open access
Semantic Scholar
Case Report: Organ procurement in a DCD donor with ovarian thecoma: abdominal NRP enabled timely and safe resection, pathological confirmation, and successful kidney transplantation
Benjamin Assouline, Timothée Olivier, A. Rougemont, Philippe Compagnon +5 more
2025Frontiers in Transplantation1 citations Open access
Semantic Scholar
[Oncology. Antibody-drug conjugates : a challenging innovation].
Rita S Brito, Timothée Olivier, A. Wolfer
2025Revue medicale suisse1 citations Open access
Semantic Scholar
ESMO Rare Cancers – a brighter future for patients with rare cancers
A. Dufresne, Timothée Olivier
2024ESMO Rare Cancers1 citations Open access
Semantic Scholar
Evolving challenges in smoldering myeloma trials: shifting endpoint measurement and definitions.
Myung Sun Kim, Vinay Prasad, Timothée Olivier
2026Journal of Cancer Policy0 citations Open access
Semantic Scholar
Time-of-Day Immunotherapy: Why the Field Still Needs Randomized Evidence.
V. Subbiah, A. Addeo, Timothée Olivier
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Twelve mutations, three trials, and five different labels: PARP inhibitors regulatory inconsistencies in prostate cancers
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, H. M. Westgeest, Timothée Olivier
2025EClinicalMedicine0 citations
Semantic Scholar
Cross sectional analysis of Long-term overall survival among patients taking immune checkpoint inhibitor drugs.
A. Haslam, Timothée Olivier, V. Prasad
2025Journal of Cancer Policy0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Addeo×3
Invite
A. Addeo — researcher profile on SciRah
Kaushal Parikh×2
Invite
Kaushal Parikh — researcher profile on SciRah
Maxime Borgeaud×1
Invite
Maxime Borgeaud — researcher profile on SciRah
J. Bar×1
Invite
J. Bar — researcher profile on SciRah

×1

Invite

S. Saw — researcher profile on SciRah

Invite

G. Banna — researcher profile on SciRah

Invite

C. De Vito — researcher profile on SciRah

Jill Feldman×1

Invite

Jill Feldman — researcher profile on SciRah

Invite

X. Le — researcher profile on SciRah

Hiba Mechahougui×1

Invite

Hiba Mechahougui — researcher profile on SciRah

Invite

L. Royston — researcher profile on SciRah

Catia Vieira Gomes×1

Invite

Catia Vieira Gomes — researcher profile on SciRah